Table 1.
The information of flavivirus vaccines.
| Vaccine | Vaccine Type | Antigen | An-Virus | Stage |
|---|---|---|---|---|
| 17D | Live attenuated vaccine | E protein | YFV | licensed |
| SA14-14-2 | Live attenuated vaccine | E protein | JEV | licensed |
| TV003 | Live attenuated vaccine | prM-E | DENV1–4 | Phase III |
| DENVax | Live attenuated vaccine | prM-E | DENV1–4 | Phase III |
| FSME-IMMUN | Inactivated vaccine | E protein | TBEV | licensed |
| Encepur | Inactivated vaccine | E protein | TBEV | licensed |
| Evervac | Inactivated vaccine | E protein | TBEV | Phase II |
| TDENV-PIV | Inactivated vaccine | C-prM-E-NS1/3/5 | DENV1–4 | Phase I |
| ZPIV | Inactivated vaccine | E protein | ZIKV | Phase I |
| CYD-TDV(Dengvaxia) | Recombinant vaccine | prM-E | DENV1–4 | licensed |
| ChimeriVax-WN02 | Recombinant vaccine e | prM-E | WNV | Phase II |
| V180 | Recombinant vaccine | E protein | DENV1–4 | Phase I |
| ZIKV-VLP | VLPs(Virus-like particles) | C-prM-E-NS2B/NS3 | ZIKV | Animal |
| DENV-VLP | VLPs(Virus-like particles) | prM-E | DENV1–4 | preclinical |
| GLS-5700 | DNA vaccine | prM-E/NS1 | ZIKV | Phase I |
| IgEsig-prM-E-LNP | mRNA vaccine | prM-E | ZIKV | Animal |